CompareMarketResearchRequest a sample
Home / Healthcare / Amniotic Membrane

Healthcare · Market report

Amniotic Membrane Market Size, Share and Forecast 2026-2036

The global amniotic membrane market is worth USD 2.2 bn in 2026 and is forecast to reach USD 4.9 bn by 2036, growing at a 8.5% CAGR. United States is the largest country market and Dehydrated grafts is the largest by product form segment.

USD 2.2 bnMarket size 2026
USD 4.9 bnForecast 2036
8.5%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global amniotic membrane market is worth USD 2.2 bn in 2026 and is forecast to reach USD 4.9 bn by 2036, growing at a 8.5% CAGR. United States is the largest country market and Dehydrated grafts is the largest by product form segment.

ScopeProcessed human amniotic membrane grafts and products used in wound care, ophthalmic surgery, orthopaedics and dental procedures, sold as sheets, powders, injectables and cryopreserved or dehydrated grafts.
IndustryHealthcare
Value 2025USD 2.0 bn
Value 2026USD 2.2 bn
Value 2036USD 4.9 bn
CAGR 2026-20368.5%
Volume 20261,735 thousand grafts
Volume 20363,733 thousand grafts
Average price 2026USD 1,256 per graft
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Amniotic Membrane market size and forecast, 2026-2036

Exhibit 1The global amniotic membrane market is forecast to grow from USD 2.2 bn in 2026 to USD 4.9 bn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 8.5%
Amniotic Membrane market value, 2025 to 2036Market value by year. 2025: USD 2.0 bn; 2026: USD 2.2 bn; 2027: USD 2.4 bn; 2028: USD 2.6 bn; 2029: USD 2.8 bn; 2030: USD 3.0 bn; 2031: USD 3.3 bn; 2032: USD 3.6 bn; 2033: USD 3.9 bn; 2034: USD 4.2 bn; 2035: USD 4.5 bn; 2036: USD 4.9 bn. Compound annual growth rate 2026 to 2036: 8.5%.20252.2 bn20263.3 bn20314.9 bn20368.5% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 2.2 bn
2027USD 2.4 bn
2028USD 2.6 bn
2029USD 2.8 bn
2030USD 3.0 bn
2031USD 3.3 bn
2032USD 3.6 bn
2033USD 3.9 bn
2034USD 4.2 bn
2035USD 4.5 bn
2036USD 4.9 bn

Amniotic Membrane market segmentation

By product form

Exhibit 2Dehydrated grafts is the largest segment by product form, with 46.0% of 2026 revenueEstimated share of 2026 global revenue, by product form
Amniotic Membrane market share by product form, 2026Share of 2026 revenue by product form. Dehydrated grafts: 46.0%; Cryopreserved grafts: 24.0%; Fluid and injectable products: 18.0%; Powders and other forms: 12.0%.Dehydrated grafts46.0%Cryopreserved grafts24.0%Fluid and injectable products18.0%Powders and other forms12.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Dehydrated grafts46.0%42.6%USD 1.0 bn7.7%
Cryopreserved grafts24.0%23.7%USD 523 mn8.4%
Fluid and injectable products18.0%22.3%USD 392 mn10.9%
Powders and other forms12.0%11.3%USD 262 mn7.9%

By application

Exhibit 3Chronic wound care adds the most revenue by application, growing from USD 1.1 bn in 2026 to USD 2.5 bn by 2036Estimated revenue in USD by application, 2026 and 2036 forecast
Amniotic Membrane market by application, 2026 and 2036Revenue by application in 2026 and 2036. Chronic wound care: USD 1.1 bn in 2026, USD 2.5 bn in 2036, change +124%; Ophthalmology: USD 436 mn in 2026, USD 1.0 bn in 2036, change +135%; Surgical and orthopaedic: USD 349 mn in 2026, USD 804 mn in 2036, change +130%; Dental and other: USD 262 mn in 2026, USD 560 mn in 2036, change +114%.20262036 forecastChangeChronic wound care+124%1.1 bn2.5 bnOphthalmology+135%436 mn1.0 bnSurgical and orthopaedic+130%349 mn804 mnDental and other+114%262 mn560 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Chronic wound care52.0%51.6%USD 1.1 bn8.4%
Ophthalmology20.0%20.8%USD 436 mn8.9%
Surgical and orthopaedic16.0%16.3%USD 349 mn8.7%
Dental and other12.0%11.4%USD 262 mn7.9%

By tissue layer

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Amnion46.0%44.0%USD 1.0 bn8.0%
Amnion-chorion28.0%29.0%USD 610 mn8.9%
Umbilical cord and Wharton's jelly26.0%27.0%USD 567 mn8.9%

By end user

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Hospitals42.0%40.0%USD 916 mn8.0%
Ambulatory surgery centres22.0%23.0%USD 480 mn9.0%
Wound care clinics24.0%25.0%USD 523 mn8.9%
Eye clinics12.0%12.0%USD 262 mn8.5%

By processing method

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Terminally sterilised48.0%47.0%USD 1.0 bn8.3%
Aseptically processed38.0%38.0%USD 828 mn8.5%
Lyophilised and powdered14.0%15.0%USD 305 mn9.2%

Top 25 countries for amniotic membrane by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 94.5% of 2026 revenue and the 25 countries below together hold 98.4%.

Exhibit 4United States is the largest country market at USD 1.5 bn in 2026, and the three largest countries hold 76.5% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Amniotic Membrane market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 1.5 bn, 68.0%; Germany: USD 98 mn, 4.5%; China: USD 87 mn, 4.0%; Japan: USD 76 mn, 3.5%; United Kingdom: USD 76 mn, 3.5%; France: USD 65 mn, 3.0%; India: USD 54 mn, 2.5%; Italy: USD 44 mn, 2.0%; Canada: USD 44 mn, 2.0%; Brazil: USD 33 mn, 1.5%.United States1.5 bn 68.0%Germany98 mn 4.5%China87 mn 4.0%Japan76 mn 3.5%United Kingdom76 mn 3.5%France65 mn 3.0%India54 mn 2.5%Italy44 mn 2.0%Canada44 mn 2.0%Brazil33 mn 1.5%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 1.5 bn68.0%USD 3.2 bn8.0%
2GermanyUSD 98 mn4.5%USD 232 mn9.0%
3ChinaUSD 87 mn4.0%USD 271 mn12.0%
4JapanUSD 76 mn3.5%USD 168 mn8.2%
5United KingdomUSD 76 mn3.5%USD 173 mn8.5%
6FranceUSD 65 mn3.0%USD 148 mn8.5%
7IndiaUSD 54 mn2.5%USD 168 mn11.9%
8ItalyUSD 44 mn2.0%USD 99 mn8.5%
9CanadaUSD 44 mn2.0%USD 99 mn8.5%
10BrazilUSD 33 mn1.5%USD 84 mn9.9%
11SpainUSD 9.4 mn0.4%USD 20 mn7.7%
12AustraliaUSD 9.4 mn0.4%USD 20 mn7.7%
13South KoreaUSD 8.5 mn0.4%USD 20 mn9.0%
14NetherlandsUSD 6.8 mn0.3%USD 14 mn7.8%
15MexicoUSD 6.8 mn0.3%USD 16 mn9.2%
16SwitzerlandUSD 5.9 mn0.3%USD 12 mn7.7%
17TurkeyUSD 5.0 mn0.2%USD 13 mn10.2%
18Saudi ArabiaUSD 5.0 mn0.2%USD 13 mn10.2%
19ArgentinaUSD 4.1 mn0.2%USD 8.9 mn7.9%
20PolandUSD 4.1 mn0.2%USD 9.9 mn9.1%
21IsraelUSD 4.1 mn0.2%USD 9.9 mn9.1%
22RussiaUSD 4.1 mn0.2%USD 8.9 mn7.9%
23BelgiumUSD 4.1 mn0.2%USD 8.9 mn7.9%
24SwedenUSD 4.1 mn0.2%USD 8.9 mn7.9%
25SingaporeUSD 3.5 mn0.2%USD 7.9 mn8.5%
Rest of worldUSD 35 mn1.6%USD 84 mn9.2%
Exhibit 5United States and China account for 70% of the USD 2.7 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Amniotic Membrane market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 2.2 bn. United States: +USD 1.7 bn; China: +USD 184 mn; Germany: +USD 134 mn; India: +USD 113 mn; United Kingdom: +USD 96 mn; 20 other countries: +USD 442 mn; Rest of world: +USD 49 mn. Market value 2036: USD 4.9 bn.Market value 20262.2 bnUnited States+1.7 bnChina+184 mnGermany+134 mnIndia+113 mnUnited Kingdom+96 mn20 other countries+442 mnRest of world+49 mnMarket value 20364.9 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • MiMedx Group
  • Organogenesis
  • Smith & Nephew
  • TissueTech
  • Celularity
  • AlloSource
  • MTF Biologics

Group 2: Regional and specialist players

  • Integra LifeSciences
  • Bioventus
  • Katena Products
  • Surgenex
  • StimLabs
  • BioStem Technologies
  • Amnio Technology
  • Applied Biologics
  • Tides Medical
  • Vivex Biomedical

Group 3: Emerging and niche players

  • BioLab Sciences
  • LifeNet Health
  • Sanara MedTech
  • Tissue Regenix
  • Elutia

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the amniotic membrane market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 8.5% is calculated from the resulting values.

The market is divided by product form, by application, by tissue layer, by end user, by processing method. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the amniotic membrane market?

The global amniotic membrane market is estimated at USD 2.0 bn in 2025 and USD 2.2 bn in 2026.

How fast will the amniotic membrane market grow?

It is forecast to reach USD 4.9 bn by 2036, a compound annual growth rate of 8.5% from 2026, an increase of USD 2.7 bn.

Which country is the largest market for amniotic membrane?

United States is the largest market by revenue at USD 1.5 bn in 2026, 68.0% of the global total. The three largest countries together hold 76.5%.

Which country is growing fastest?

Among the ten largest markets, China is growing fastest at 12.0% a year from 2026 to 2036.

Which amniotic membrane segment is largest?

In the by product form split, Dehydrated grafts is the largest segment with 46.0% of 2026 revenue.

Who are the leading amniotic membrane companies?

Global leaders include MiMedx Group, Organogenesis, Smith & Nephew, TissueTech.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Ambulatory Surgery Center Ampoule →

All Healthcare markets →

Request a sample